Seno Medical commercially launches Imagio breast imaging system

2020 01 02 17 50 4501 Breast Cancer3 400

Optoacoustic imaging firm Seno Medical Instruments is officially launching the now commercially available Imagio breast imaging system at RSNA 2022.

The system uses a combination of noninvasive ultrasound and optoacoustic technology to provide information about breast lesions in real-time. It combines laser optics and grayscale ultrasound to provide fused functional and anatomical breast imaging.

The optoacoustic images provide a unique blood map in and around breast masses, while the ultrasound provides a traditional anatomic image. The system is designed to help radiologists confirm or rule out malignancy of suspicious breast lesions, and it includes the SenoGram artificial intelligence decision-support tool.

Page 1 of 509
Next Page